About Us
The C2PO, Comprehensive Center for Precision Oncology, is a research center of the University of São Paulo (USP).
Created in 2023, C2PO was established with a dual mission: to coordinate research carried out across different USP Units and to disseminate high-quality scientific information.
The first mission of C2PO is to bring together research and innovation groups already active at the University, promoting the circulation of knowledge produced by these groups and encouraging the sharing of infrastructure available in USP’s various laboratories. In addition, the center is also tasked with making the work developed by USP scientists publicly accessible.
The second mission of the center is to provide the public with high-quality scientific information, dismantling stigmas and prejudices about cancer while combating misinformation.
C2PO is based at the São Paulo State Cancer Institute (ICESP) and at the Oncology Center of the Hospital das Clínicas de Ribeirão Preto (CEONCO).
Coordination
Coordinator
Vice-Coordinator
Roger Chammas
Faculdade de Medicina
Universidade de São Paulo
Leandro Machado Colli
Faculdade de Medicina de Ribeirão Preto
Universidade de São Paulo
Management Committee
Adriano Defini Andricopulo
Instituto de Física de São Carlos
Universidade de São Paulo
Ana Paula Lepique
Instituto de Ciências Biomédicas
Universidade de São Paulo
Carlos Alberto Labate
Escola Superior de Agricultura Luiz de Queiroz
Universidade de São Paulo
Maria Del Pilar Estevez Diz
Faculdade de Medicina
Universidade de São Paulo
Maria Lucia Zaidan Dagli
Faculdade de Medicina Veterinária e Zootecnia
Universidade de São Paulo
Rodolfo Borges dos Reis
Faculdade de Medicina de Ribeirão Preto
Universidade de São Paulo
Advisory Committee
Ana Marisa Chudzinski-Tavassi
Instituto Butantan
Antonio José Roque da Silva
The Brazilian Center for Research in Energy and Materials (CNPEM)
Elisabete Weiderpass
International Agency for Research on Cancer (IARC)
Fernanda Tovar-Moll
Instituto D’Or de Ensino e Pesquisa
José Eduardo Levi
DASA
Luciana Holtz de Camargo Barros
Oncoguia
Mariana Emerenciano Cavalcanti Sá
Brazilian National Cancer Institute (INCA)
Miriam Merad
Precision Immunology Institute at Icahn School of Medicine (PrIISM)
Natália Neto Pereira Cerize
Institute for Technological Research of the State of São Paulo (IPT)
Stephen J. Chanock
National Cancer Institute (NCI)